Our recent research
Research is at the centre of everything we do within Critical Care at Cambridge.
The University Division of Anaesthesia (UDA) is led by Professor David Menon while other established University posts at Consultant level include three University Lecturers; one in Neurocritical Care (Dr Jonathan Coles), one in Pain Medicine (Dr Michael Lee), and one in Intensive Care Medicine (Dr Charlotte Summers) while several NHS consultants also have a research base within the UDA, including Dr Ram Adapa (mechanisms of anaesthesia and consciousness) and Dr Ari Ercole (non-linear analysis of complex physiological data).
We also host non-established ICM-related clinical academics, including Dr Virginia Newcombe (AMS Clinician Scientist), Dr Andy Conway-Morris (Clinical Lecturer in Anaesthesia), Dr Alasdair Jubb (Clinical Lecturer in Anaesthesia), amongst others. The Division also currently supports several PhD students and a variety of postgraduate/post-doctoral research workers.
The UDA is currently supported by grant funding from the NIHR, Wellcome Trust, MRC, EU FP7 program, and other sources.
JVFICU has an active programme of experimental medicine studies relating to sepsis, ARDS and nosocomial infection. JVFICU has world-recognised expertise in the translation of basic science into first-in-human and first-in-patient studies of therapeutics in these clinical domains, and work closely with several pharmaceutical companies on the development of novel agents for critically ill patient populations.
Dr Summers, a JVFICU consultant and University Lecturer, also collaborates with Papworth CTICU on a number of research projects in addition to her other national and international research collaborations.
We participate in a range of mul-ticentre interventional clinical trials across Cambridge.
NCCU has a busy, vibrant research programme focussed on acute brain injury and complex trauma. Projects include CENTER-TBI which is a prospective longitudinal observational study in 60 centres from 20 countries including approximately 5400 patients which will obtain detailed data on the entire clinical course on injury details, treatment, outcome and health costs following traumatic brain injury
Research at CTICU at Papworth adopts a multifaceted approach to understanding critical illness in the context of cardiothoracic disease. Recently we have been engaged in research into outcomes following aprotonin usage, ECMO utilisation during the H1N1 pandemic; pulmonary embolus; and sickle cell disease, outcomes following pulmonary endarterectomy, genotype and phenyotype characterisation of renal outcomes following cardiac surgery, and clinical information systems. In addition we have participated in a large number of multicentre international intensive care medicine trials.
This site will shortly list the research projects in Cambridge and our publications.